Mona Mohammadzadeh

Mona Mohammadzadeh

Auto-generated profile, based on publicly available information

Mona Mohammadzadeh

Pharmacoeconomy & Medical-Pharma Management Research Center; Department of Pharmacoeconomy & Administrative Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MMMona Mohammadzadeh
Mona Mohammadzadeh
BPBabak Pourakbari
Babak Pourakbari
SMShima Mahmoudi
Shima Mahmoudi
AKAbbas Keshtkar
Abbas Keshtkar
MHMahdi Habibi-Anbouhi
Mahdi Habibi-Anbouhi
SMSetareh Mamishi
Setareh Mamishi

28 February 2023 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SMS. Mohammadzadeh
S. Mohammadzadeh
FSF. Salmannejad
F. Salmannejad
MMM. Mohammadzadeh
M. Mohammadzadeh
TGT. Ghari
T. Ghari
SSS. Sadrai
S. Sadrai
JZJ. Zaringhalam
J. Zaringhalam
Introduction. As the first approved drug for amyotrophic lateral sclerosis (ALS) treatment, riluzole is known as a glutamatergic neurotransmission inhibitor administrated in 50 mg tablets twice daily. For this reason, a generic product of riluzole has been developed at a lower price by Hogar-Daroo, Iran, which would benefit patients.Aim. The objective of this study is to develop and validate a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the analysis of riluzole in human plasma samples and its application in the bioequivalence study of riluzole tablet.Materials and methods. The chromatography was performed by using a C18 column (100 mm, 4.6 mm, 5 mm), 0.1 % formic acid and acetonitrile (60 : 40, v/v) as the mobile phase, at a flow rate of 0.90 ml/min in the gradient program. Carbamazepine was used as an internal standard (IS). The method employed only 100 µL of human plasma for quantification by a liquid-liquid extraction technique. The multiple reaction monitoring modes (MRM) was used for quantification of ion transitions m/z 235.0/165.9 and m/z 137.6/110.0 for riluzole and the m/z 236.9/194.0 for the IS. Dwell time was set at 200 ms.Results and discussion. The calibration curve was linear over the concentration range 0.5–300 ng/mL. The lower limit of quantitation (LLOQ) was obtained at 0.5 ng/mL. The intra-day and inter-day accuracy ranged from 93.21 % to 101.34 % and 91.77 % to 104.88 % respectively. The intra-day and inter-day precision values ranged from 2.19 % to 5.69 % and 1.67 % to 5.31 % respectively, all within the FDA acceptable ±15 %.Conclusion. The validated method was applied in Iranian healthy subjects under fasting condition with a 50 mg riluzole tablet successfully.